Lead sponsor

University College, London

6 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

6

Trials led

1

Active

484

Total enrollment

3

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 2
3
Phase 3
2
Phase 4
1

Trials by status

Active, not recruiting
1
Completed
4
Unknown
1

Trials led

Exenatide-PD3Ph 3Completed194
BARI-STEPPh 3Active, not recruiting70
BARIOPTIMISEPh 4Completed70
EXENATIDE-PDPh 2Completed60
MSAPh 2Completed50